Solving Kids`Cancer – Funding for High-Impact Pediatric Cancer Research: Therapeutic Development Initiative (TDI)
05/12/2017 13:51
Objetivo: The Therapeutic Development Initiative (TDI) is SKC’s strategic platform for the implementation of its research agenda as well as the vehicle for reviewing and prioritizing submitted research proposals. The TDI’s goal is to support innovative clinical studies that are high on the risk/reward spectrum while, at the same time, investigating these research questions efficiently and effectively. Priority is given to proposals that introduce therapeutic agents and modalities which are first-in-children and have a strong potential to improve treatment outcomes.
Inscrições: durante todo o ano
Mais informações no site.
